Efficacy of dupilumab for the treatment of severe skin disease in cytotoxic T lymphocyte antigen-4 insufficiency: A role of type 2 inflammation?

por Arruda, L. Karla, Cordeiro, Daniel L., Langer, Sarah S., Koenigham-Santos, Marcel, Calado, Rodrigo T., Dias, Marina M., Anhesini, Leonardo R., Oliveira, João Bosco, Grimbacher, Bodo, Ferriani, Mariana P.L.
Publicado 2022